(Q38908262)

7 September 2017

title

Oral Idarubicin in Elderly Acute Leukemia and Myelodyplastic Syndromes (English)

1 reference

7 September 2017

1 reference

A Berrebt

1

1 reference

7 September 2017

A Polllack

series ordinal

2

1 reference

7 September 2017

publication date

1 January 1990

1 reference

7 September 2017

1 reference

7 September 2017

volume

2

1 reference

7 September 2017

issue

5

1 reference

7 September 2017

page(s)

287-290

1 reference

Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199009106463

Refractory anemia with excess of blast cells: prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients. Cooperative Group for the Study of Aplastic and Refractory Anemias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199009106463

Response of preleukemic syndromes to continuous infusion of low-dose cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199009106463

Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199009106463

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199009106463

4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199009106463

10.3109/10428199009106463

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference